Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
4.81B
Dividend Yield
0.00%
P/E Ratio
-12.48
EPS
-4.35
Revenue
37.31M
Avg. Volume
3.09M

Recently from Cashu

publisher logo
Cashu

CRISPR Therapeutics AG: Leading Innovations and Ethical Practices in Genetic Engineering

2 days ago
publisher logo
Cashu

CRISPR Therapeutics AG: Leading Innovations in Gene Editing for Genetic Disease Treatments

4 days ago
publisher logo
Cashu

Ark Invest Boosts Confidence in CRISPR Therapeutics AG's Innovative Healthcare Solutions

5 days ago
Stocks
Health Care
crsp
CRISPR Therapeutics AG
NASDAQ: CRSP
-0.19 (-0.34%)
56.07
USD
At close at Aug 01, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials

About

What does CRSP do?
CRISPR Therapeutics AG, headquartered in Zug, develops gene-based medicines for serious diseases using its CRISPR/Cas9 platform and went public on October 19, 2016. The company focuses on gene editing to treat genetically-defined diseases and enhance cellular therapies.
Sector
💻 Health Care
IPO
CEO
Employees
393 employees
Headquarters
Switzerland
Website
http://www.crisprtx.com